Intracellular reactive oxygen species (ROS) induced DNA‐PKcs phosphorylation in DCs, and pharmacological inhibition or specific abolishment of DNA‐PKcs in DCs attenuated anaphylaxis, indicating that DNA‐PKcs is a promising target in the treatment of allergic asthma.78 This evidence concerns the gene PRKDC and allergic asthma.